Walgreens to make various CBD-products available in 1500 stores
Category: #retail  By Shikha Sinha  Date: 2019-03-29
  • share
  • Twitter
  • Facebook
  • LinkedIn

Walgreens to make various CBD-products available in 1500 stores

Walgreens, the American health & wellness major, has reportedly announced its plans to sell several CBD (Cannabidiol)-infused products including creams, sprays and patches, in around 1,500 of its stores in select states. Sources claim that the company will be selling the cannabis products in Kentucky, Vermont, Oregon, New Mexico, Tennessee, Colorado, Indiana, Illinois and South Carolina.

The latest move comes after CVS Health Corp., a contending drugstore chain, introduced topicals such as slaves and creams, to several stores across eight states in March this year. With CBD – the non-psychoactive cannabis compound – currently trending as one of the most appealing ingredients in consumer products, retailers are focusing on launching it into the market, cite market experts.

Brian Faith, a spokesman for Walgreens, recently said that the company’s latest product offering is aligned with its endeavor in making a broader array of health & well-being products and services accessible to targeted consumers and meet their preferences as well as needs in the best possible way.

Apparently, consumers have grown highly curious about CBD, that is widely ruminated to be helping conditions like pain and anxiety. Reports state that CBD, which is derived from hemp, is now legalized, given that the Congress passed the farm bill last year. The sale of CBD-based beauty & skincare products has therefore turned easier for most retailers.

In a recent statement, Walgreens revealed that marijuana has widely been deployed to relieve pain and psychological & digestive disorders for over 3,000 years, and yet the safety, efficiency and legality of the drug are still disputed. The company further affirmed that research on marijuana’s health benefits is currently in progress, while mentioning a few recent studies that claim cannabinoid receptors to be playing significant roles in certain biological processes including bone growth, metabolic regulation, cravings, immune function, anxiety and pain.

Other popular brands, for the record, are also coming up with CBD-based products, for instance, Coca-Cola’s proposed launch of cannabis-infused drinks and CBD jelly beans by Jelly Belly.



About Author

Shikha Sinha

Email: [email protected]   

Shikha Sinha

Shikha currently manages content operations for a series of news and business portals including MSF, Algosonline, and the like. An electrical & electronics engineer by education, she has prior experience in content & technology writing, content marketing, market resea...

Read More

More News By Shikha Sinha

Altimmune inks deal to acquire Spitfire Pharma and its NASH candidate
Altimmune inks deal to acquire Spitfire Pharma and its NASH candidate
By Shikha Sinha

Altimmune, Inc., a clinical stage biopharma company, has recently confirmed the closing of a formerly announced acquisition of Spitfire Pharma, Inc., including the strong GLP-1/Glucagon receptor co-agonist product cand...

NeurologyLive expands SAP program by partnering with Cleveland Clinic
NeurologyLive expands SAP program by partnering with Cleveland Clinic
By Shikha Sinha

NeurologyLive has reportedly added the Cleveland Clinic to its Strategic Alliance Partnership (SAP) program. Michael J. Hennessy Jr., President of NeurologyLive’s parent company MJH Associates Inc., said in a sta...

Neurocrine, Voyager reveal VY-AADC’s Phase I results at AAN 2019
Neurocrine, Voyager reveal VY-AADC’s Phase I results at AAN 2019
By Shikha Sinha

Neurocrine Biosciences Inc., along with Voyager Therapeutics Inc., has reportedly announced the Phase 1 results from the VY-AADC trial in eight patients suffering from Parkinson’s disease. Apparently, the patient...